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Abstract: Hydrolyzed wheat proteins (HWPs) are widely used as functional ingredients in foods and
cosmetics, because of their emulsifying and foaming properties. However, in individuals suffering
from celiac disease or wheat allergy, HWPs may have a modified immunoreactivity compared to
native gluten due to changes in molecular structures. Although a variety of HWPs are commercially
available, there are no in-depth comparative studies that characterize the relative molecular mass
(Mr) distribution, solubility, and hydrophilicity/hydrophobicity of HWPs compared to native gluten.
Therefore, we aimed to fill this gap by studying the above characteristics of different commercial
HWP and gluten samples. Up to 100% of the peptides/proteins in the HWP were soluble in aqueous
solution, compared to about 3% in native gluten. Analysis of the Mr distribution indicated that
HWPs contained high percentages of low-molecular-weight peptides/proteins and also deamidated
glutamine residues. We also found considerable differences between the seven HWPs studied, so that
each HWP needs to be studied in detail to help explain its potential immunoreactivity.
Keywords: celiac disease; gel electrophoresis; gliadin; gluten; high-performance liquid
chromatography (HPLC); hydrolyzed wheat proteins; wheat allergy
1. Introduction
Wheat gluten is the viscoelastic mass that remains when starch and other water-soluble components
are washed out of wheat dough [1]. According to Codex Standard 163–1987, wheat gluten consists
of >80% protein, 5–10% lipids, and residues of starch and non-starch polysaccharides [2]. The term
“gluten” describes a mixture of over 100 different proteins with a mono-, oligo-, or polymeric structure.
Oligomeric and polymeric proteins consist of monomers linked by interchain disulfide bonds. Gluten
proteins contain high amounts of glutamine (Gln/Glu: 37.1 mol-% in gliadins, 30.1 mol-% in glutenins)
and proline (16.6 mol-% in gliadins, 11.9 mol-% in glutenins) as well as low amounts of amino acids
with charged side chains, such as lysine (0.8 mol-% in gliadins, 2.1 mol-% in glutenins) [1,3]. According
to the so-called Osborne fractionation, gluten proteins can be divided into two protein fractions
depending on their solubility, the gliadins and the glutenins. Gliadins are soluble in 60% ethanol,
whereas glutenins remain insoluble [4,5]. Furthermore, gluten proteins can be subdivided by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or reversed-phase high-performance
liquid chromatography (RP-HPLC) into gluten protein types: α-, γ-, ω1,2-, and ω5-gliadins and
high- and low-molecular-weight glutenin subunits (HMW-GS and LMW-GS) [5–7].
Gliadins consist of mostly monomeric and glutenins of oligomeric and polymeric proteins.
Gluten is responsible for the unique baking properties of wheat flour, by building a viscoelastic gluten
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network [1,7]. Wheat gluten is often used as an ingredient to improve and standardize the baking
properties of wheat flours [1,8].
Furthermore, gluten is also used in various non-cereal products, in which the consumer generally
does not expect gluten to be present. For example, wheat gluten is used as binding or protein-enriching
agent in meat products or even cosmetics [9,10]. To improve wheat gluten solubility, it is treated
in different chemical and biochemical ways, leading to modifications and/or partial hydrolysis.
Deamidation of proteins takes place during hydrolysis with acid or alkali. In the case of enzymatic
hydrolysis, the deamidation depends on the enzyme used [8–10]. Hydrolysis leads to the formation of
proteins or peptides with lower relative molecular masses (Mr) and deamidation to changes of the net
charge. Both processes increase the solubility of gluten. Treatment with alkali removes intermolecular
disulfide bonds, but usually, it does not lead to a cleavage of peptide bonds [8,11]. Sodium hydroxide
is typically used for alkaline hydrolysis; hydrochloric acid or sulfuric acid for acidic hydrolysis; and
enzymes like papain, trypsin, and pronase for enzymatic hydrolysis [8,12,13]. Furthermore, gluten
can be modified by physical means, like high-pressure processing, heat treatment, extrusion, and UV
irradiation [8,14,15].
Wheat is one of the most common foods that may cause adverse reactions, such as celiac
disease, non-celiac gluten sensitivity, and wheat allergy. Celiac disease is a chronic small intestinal
immune-mediated enteropathy in genetically predisposed individuals, caused by the ingestion of
gluten. Its estimated prevalence is about 1% of the population worldwide, with 0.7% reported based
on biopsy-confirmed cases and 1.4% reported based on seroprevalence [16]. Wheat allergy has a
prevalence of 0.2–1% and is defined as an adverse immune response, with intestinal and extraintestinal
symptoms occurring within minutes or hours after exposition [17]. Thereby, the exposition triggering
the immunoglobulin E (IgE)-mediated allergy can be through inhalation, skin contact, or oral ingestion.
Wheat allergy can be classified into immediate food allergy, wheat-dependent exercise-induced
anaphylaxis (WDEIA), respiratory allergy, and skin allergy. Gluten proteins and inhibitors in wheat
have been identified to play a key role in wheat allergy [17,18]. WDEIA is a cofactor-triggered
wheat allergy and is subdivided into conventional-WDEIA (CO-WDEIA) and hydrolyzed wheat
protein-WDEIA (HWP-WDEIA). In CO-WDEIA, patients react to native gluten proteins, whereas in
HWP-WDEIA, patients are sensitized to HWP but tolerate native gluten. This underlines that hydrolysis
affects the immunoreactivity of wheat proteins [19]. Allergic reactions to soap and cosmetics containing
HWPs were reported [20,21]. Parts of the relevant immunoreactive epitopes are already pre-existent in
native wheat protein aggregations and are laid bare through hydrolysis but not destroyed. Besides,
new epitopes may be created through hydrolysis and simultaneous deamidation [20,21]. Additionally,
the increased solubility of the HWP and the route of exposure also affects the immunoreactivity of HWP
compared to the native form. Consequently, the degree and type of hydrolysis play an important role,
because this could affect the transport through natural barriers, such as the small intestinal epithelium
or the skin [19–22].
Gluten is used as the starting material for the production of HWP, which may also be called
partially hydrolyzed gluten to better reflect this. There are various methods of how gluten can be
hydrolyzed, including chemical, biochemical, and physical approaches, leading to highly variable
preparations of HWP. In most cases, the functional properties of the HWP were described as emulsifying
or foaming [8,23]. Additionally, the sensory properties were analyzed as well as the use of HWP as a
nutritional additive. When characterizing the proteins and peptides in HWP, biochemical analyses, such
as enzyme-linked immunosorbent assays (ELISAs) or Western blots, are widely used [23–30]. However,
there are only few studies on commercially available HWP compared to native gluten. Gessendorfer
et al. (2009) prepared three enzymatically hydrolyzed prolamins from wheat, rye, and barley and
characterized the resulting HWP using ELISA, SDS-PAGE, and RP-HPLC [31]. Wieser and Scherf
developed a well-characterized HWP for diagnosis and clinical investigations of wheat-related
disorders [32], but comprehensive comparative investigations on commercially available HWP are
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missing. Additionally, the detection of modified gluten proteins can be done with ELISA or polymerase
chain reaction (PCR) [9,33–35].
Considering the differences between HWP and native gluten in terms of immunoreactivity, it is
reasonable to hypothesize that various treatments cause changes in the molecular structures of gluten.
Consequently, there is a need to characterize commercial HWP in comparison to native gluten. In the
present study, gluten and commercially available HWP products were analyzed for their crude protein
contents, solubility, and Mr distribution of the proteins and peptides as well as the contents of free
ammonium as an indicator for deamidation.
2. Materials and Methods
2.1. Reagents and Materials
All reagents and chemicals were from Merck (Darmstadt, Germany), Sigma-Aldrich
(Darmstadt, Germany), Serva (Heidelberg, Germany), Applichem (Darmstadt, Germany), Carl Roth
(Karlsruhe, Germany), Honeywell (Offenbach, Germany), and J.T. Baker (Arnhem, Netherlands) in
analytical grade or higher. Ultra-pure water for HPLC was purified with an Arium 611VF water
purification system (Sartorius, Goettingen, Germany). Prolamin Working Group (PWG)-gliadin was
used for calibration, which is well suited to quantitate all types of different wheat proteins [5,7,36].
Wheat gluten and HWP were obtained from Hermann Kröner GmbH (Ibbenbueren, Germany),
Sigma-Aldrich (Darmstadt, Germany), Mühle Schlingemann (Waltrop, Germany), Tereos (Lille, France),
Solabia Group (Pantin, France) Manildra Group (Gladesville, Australia), Golden Peanut GmbH
(Garstedt, Germany), Reform- und Muehlenbaeckerei Boesen GmbH (Langenfeld, Germany), and Tate
& Lyle (Aalst, Belgium). Seven HWP (HWP 1–7), six gluten samples (G1–6), and two treated
gluten samples (G7, G8) were purchased. G7 is described as denatured wheat protein with a high
protein content and G8 as a slightly textured product from wheat protein. Protein/peptide markers
used for the gel-permeation HPLC were purchased from Sigma-Aldrich (Darmstadt, Germany):
β-amylase from sweet potato (200 kDa), albumin from bovine serum (66 kDa), carbonic anhydrase
from bovine erythrocytes (29 kDa), cytochrome c from horse heart (12.4 kDa), α-lactalbumin (14 kDa),
and glutathione (0.3 kDa). Furthermore, a gluten peptide (1.9 kDa) was received from Genescript
Biotech (Piscataway Township, NJ, USA).
2.2. Determination of Crude Protein Contents
The crude protein content of all samples was determined by the combustion method according to
Dumas (ICC Standard Method No.167). The samples were analyzed using a Leco TruSpec Nitrogen
Analyzer (LECO, Mönchengladbach, Germany) to determine the nitrogen content after combustion at
950 ◦C. Ethylenediaminetetraacetic acid (EDTA) was used for calibration. The nitrogen content was
multiplied by the factor 5.7 to calculate the crude protein content (wheat protein, ICC No. 105/2) [7].
2.3. Stepwise Fractionation According to Solubility
The stepwise fractionation according to solubility was performed according to the modified
Osborne method by Wieser et al. (1998) [5]. Three fractions A, B, and C were received. Fraction A is
soluble in aqueous salt solution (0.4 mol/L NaCl, 0.067 mol/L Na2HPO4/KH2PO4, pH 7.6), fraction
B is soluble in 60% ethanol (v/v), and fraction C is soluble in 1-propanol/0.05 mol/L Tris/HCl, pH 7.5
(50% (v/v), with 2 mol/L (w/v) urea and 0.06 mol/L dithiothreitol, DTT) (glutenin extraction solution).
The gluten samples G1–G8 (20 mg) were first extracted with 3 × 0.5 mL aqueous salt solution to
obtain fraction A by vortex mixing for 2 min, followed by stirring at room temperature for 30 min and
centrifugation (25 min, 3750× g, 20 ◦C). The corresponding three supernatants each were united and
filled up with the extraction solution to a volume of 2 mL. The residue was discarded.
In a separate experiment, the gluten samples G1–G8 (20 mg) were extracted with 3 × 1.5 mL
60% ethanol (v/v) by 2 min vortex mixing, 30 min stirring at room temperature, and centrifugation
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(25 min, 3750× g, 20 ◦C). The three supernatants were combined, and the volume was adjusted to
5 mL with 60% ethanol. To calculate the content of fraction B, the content of fraction A was deducted
from the 60% ethanol extract after the RP-HPLC measurement. To extract fraction C, the residue was
extracted three times with 1.5 mL of glutenin extraction solution by vortex mixing for 2 min followed
by stirring at 60 ◦C under nitrogen atmosphere for 30 min and centrifugation (25 min, 3750× g, 20 ◦C).
The supernatants were united and filled up with the extraction solvent to a volume of 5 mL. All extracts
were filtered (0.45 µm) and each sample was analyzed in triplicate (n = 3) [5,7].
HWP1–HWP7 were extracted three times with 0.5 mL aqueous salt solution to obtain fraction A.
The residue was subsequently extracted three times with 0.5 mL 60% ethanol (v/v) to obtain fraction B.
Then, the residue was extracted three times with 0.5 mL of solution C. All steps were carried out exactly
as described above, except that the final volumes were 2 mL for fractions A, B, and C, respectively.
All extracts were filtered (0.45 µm) and each sample was analyzed in triplicate (n = 3) [5,7].
2.4. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC)
Protein composition and contents in fractions A, B, and C were analyzed by RP-HPLC on a Jasco
XLC instrument (Jasco, Gross-Umstadt, Germany) using a C18 column at 60 ◦C (AcclaimTM 300, C18,
2.1 × 150 mm, 300 nm, 3 µm, Thermo Fisher Scientific, Braunschweig, Germany). The elution solvents
were 0.1% trifluorocacetic acid (TFA) in ultra-pure water (A) and 0.1% TFA in acetonitrile (B). The
flow rate was 0.2 mL/min with the following gradient: 0 min 0% B, 0.5 min 24% B, 20 min 56% B,
20.1–24.1 90% B, 24.2–30.0 min 0% B. 2) [5,7]. For G 1–8, the injection volume was 20 µL for fraction A
and C and 10 µL for fraction B. For HWP 1–8, it was necessary to vary the injection volumes, because
of the different protein contents in the fractions (1–20 µL). The absorbance at 210 nm was detected.
PWG-gliadin was dissolved in 60% ethanol (v/v) to a concentration of 2.5 mg/mL and used for external
calibration (50, 37.5, 25, 12.5, and 5 µg absolute) [36]. The limit of quantitation was estimated by
injecting different amounts of PWG-gliadin (12.5, 5.00, 3.75, 2.50, 1.25, 0.50, and 0.25 µg absolute). The
protein content of PWG-gliadin was 93.1 g/100 g. The software Jasco Chrompass was used for data
analysis (version 1.2).
2.5. Gel-Permeation High-Performance Liquid Chromatography (GP-HPLC)
To analyze the Mr of proteins and peptides in HWP and treated gluten samples, HWP1–HWP7 and
G7,8 were extracted by stepwise fractionation according to solubility. Three fractions I, II, and III were
received. Fraction I, soluble in aqueous salt solution (0.4 mol/L NaCl, 0.067 mol/L Na2HPO4/KH2PO4,
pH 7.6), corresponds to fraction A in Section 2.3. Fraction II, soluble in 60% ethanol, corresponds to
fraction B in Section 2.3. Fraction III is a mixture of ultra-pure water and acetonitrile (50/50, v/v) and
corresponds to fraction C in Section 2.3. Each fraction was extracted three times. Fraction I and II
were extracted from HWP (20.0 mg or 100 mg) as described for fractions A and B in Section 2.3 for
HWP. Fraction III was extracted from the residue three times with 0.5 mL of ultra-pure water and
acetonitrile (50/50, v/v) by vortex mixing for 2 min followed by stirring at room temperature for 30 min
and centrifugation (25 min, 3750× g, 20 ◦C). The corresponding three supernatants were united and
filled up with the respective extraction solvent to a volume of 2 mL. All extracts were filtered (0.45 µm)
and each sample was analyzed in triplicate (n = 3) [5].
For chromatographic analysis, two GP-HPLC systems were used. For larger molecules, a GP-HPLC
system according to Scherf et al. (2016) was used (system 1) [36]. A BioSep-SEC-s3000 (300 × 4.6 mm,
29 nm, 5 µm, Phenomenex) was used on a Jasco HPLC Extrema (Jasco, Gross-Umstadt, Germany) at
20 ◦C. Elution solvents A and B were used with a flow rate of 0.3 mL/min and an isocratic gradient
composition of 50% A and 50% B. Because of different protein/peptide contents in the different fractions,
the injection volumes were between 1 and 20 µL. The absorbance at 210 nm was detected. To separate
smaller molecules, a second GP-HPLC system was used with a BioBasic SEC-60 column (150 × 7.8 mm,
6 nm, 5 µm, Thermo Scientific) on the same Jasco HPLC Extrema at 20 ◦C (system 2). The elution
solvents were 0.1% TFA in ultra-pure water (A) and 0.1% TFA in acetonitrile (B). The flow rate was
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1 mL/min with an isocratic gradient composition of 70% A and 30% B for a duration of 12 min. Because
of the different protein/peptide contents in the different fractions, the injection volumes were between
5 and 20 µL.
The absorbance at 210 nm was detected [37]. The software ChromNAV was used for data analysis
(Jasco Deutschland GmbH, Pfungstadt, Germany). Proteins and peptides with known Mr were
measured to mark integration areas for a certain Mr range. β-Amylase from sweet potato (200 kDa),
albumin from bovine serum (66 kDa), carbonic anhydrase from bovine erythrocytes (29 kDa), and
cytochrome c from horse heart (12.4 kDa) were used for system 1. α-Lactalbumin (14.2 kDa), a gluten
peptide (1.9 kDa), and glutathione (0.3 kDa) were used for system 2. The area under the curve (AUC)
was integrated in each section and calculated as the percentage of the total area.
2.6. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was performed according to Lagrain et al. (2012) [6]. G1–G8 and HWP1–HWP7
were characterized by SDS-PAGE on a homogenous NuPAGE 10% polyacrylamide Bis-Tris gel
(10 × 1 mm wells) (Invitrogen, Carlsbad, CA, USA). A mixture of proteins was used as a size standard
(PageRulerTM Unstained Protein Ladder, Thermo Fisher Scientific). All samples (1.5 mg each) were
mixed with 1 mL of extraction buffer (200 g/L sucrose, 59.7 g/L Tris-HCl, 40 g/L SDS, 0.3 g/L EDTA,
0.4 g/L Coomassie blue, 0.1 g/L phenol red, 0.11 mmol/L HCl) containing 7.72 g/L DTT. After incubation
for 12 h, the samples were heated to 60 ◦C for 10 min and centrifuged (5 min, 5000× g, 20 ◦C). Two
different running buffers were used. The MOPS running buffer consisted of 20.9 g/L 3-(N-morpholino)
propane sulfonic acid (MOPS), 12.1 g/L Tris-HCl, 2 g/L SDS, 0.6 g/L EDTA, and 0.77 g/L DTT as the
reducing agent. The MES running buffer consisted of 20.9 g/L 2-(N-morpholino) ethane sulfonic acid
(MES), 12.1 g/L Tris-HCl, 2 g/L SDS, 0.6 g/L EDTA, and 0.77 g/L DTT, as the reducing agent. The running
time was 30 min at 115 mA and 200 V. The protein bands were fixed with 12% (w/w) trichloroacetic
acid for 30 min, stained with Coomassie blue for 30 min, and destained first with methanol/glacial
acetic acid/water (50/10/40, v/v/v), and then with methanol/glacial acetic acid/water (10/10/80, v/v/v).
The gels were scanned using the Gel DocTM EZ Imager (Bio-Rad Laboratories, Munich, Germany) and
the Image Lab software (Bio-Rad Laboratories, Munich, Germany). The images were converted to
grayscale [6,7].
2.7. Contents of Free Ammonium
For the determination of free ammonium in G1–G8 and HWP1–HWP7, 50 mg of sample (n = 3)
were weighed into a 50-mL two-neck round-bottom flask with a 25-mL dropping funnel with a vacuum
equalizer and a vacuum receiver. Glass wool was inserted into the vacuum receiver and wetted
with 200 µL sulphuric acid (0.5 mol/L). Vacuum was created using a vacuum pump and 5 mL of
boric acid/sodium hydroxide buffer (pH 10) were added via the dropping funnel. Ammonia was
expelled for two hours while stirring at room temperature. The glass wool was then transferred into
a 50-mL volumetric flask and the vacuum receiver was washed with water. The measurement was
performed by photometry [38]. For this purpose, the samples were mixed with 4 mL each of the
following solutions: (a) 130 g/L sodium salicylate, 130 g/L trisodium citrate dihydrate, and 970 g/L
disodium-tacanonitrosyl-(III)-ferrate-dihydrate dissolved in water; (b) 0.032 g/L sodium hydroxide
and 0.002 g/L sodium dichloro-isocyanurate dissolved in water. The flask was then filled up with water
to a volume of 50 mL and left to stand for 1 h at room temperature. The measurement was carried out
according to DIN ISO 11732 with a UV-2401 spectrophotometer PC (Shimadzu, Neufahrn, Germany)
at 655 nm. An external calibration line was prepared using ammonium sulfate [38].
2.8. Statistical Analysis
Statistical analysis was carried out with the use of Origin 19 (OriginLab Cooperation, Northampton,
MA, USA) and SigmaPlot 14 (Systat Software GmbH, Erkrath, Germany).
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3. Results
3.1. Determination of Crude Protein Contents
The untreated (G1–G6) and the treated gluten samples (G7–G8) showed comparable crude protein
contents with 703.2–855.1 and 731.6–765.0 mg/kg, respectively (Table 1). The HWP had a wider
range and HWP5 (650 mg/g) had the lowest and HWP7 (898 mg/g) the highest crude protein content.
Still, the mean values of gluten samples and HWP were quite similar (G1–G8: 773 ± 45.3 mg/g;
HWP1–HWP7: 756 ± 67.9 mg/g; total: 765 ± 57.6 mg/g). HWP5 and G4 were significantly different
from each other.
Table 1. Contents of fractions A, B, and C and their sum (SUM), crude protein and free ammonium
in the gluten samples (G1–G8) and hydrolyzed wheat proteins (HWP1–HWP7). Values are given as
means (n = 3) and different capital letters indicate significant differences between the samples in each
column (one-way ANOVA, Tukey’s post hoc test, p < 0.05).
Sample Fraction A Fraction B Fraction C SUM ProteinContent Free NH4
+
[mg/g] [mg/g] [mg/g] [mg/g] [mg/g] [mg/g]
HWP 1 400.7 G <2.3 <4.7 400.7 737.4 A,B 4.12 A,B
HWP 2 569.4 J 25.9 A <4.7 595.3 752.6 A,B 0.59 A,B
HWP 3 493.6 I <2.3 <4.7 493.6 764.9 A,B 5.00 B
HWP 4 158.2 E 237.2 E 142.5 B 537.9 737.3 A,B 0.39 A,B
HWP 5 443.4 H 118.3 B 15.4 A 577.1 649.9 A 0.13 A,B
HWP 6 280.0 F 150.2 C 162.2 B,C 592.4 750.2 A,B 0.15 A,B
HWP 7 45.8 D 423.1 G 146.5 B 615.4 898.8 B 0.56 A,B
G 1 18.4 C 410.9 G 191.8 C,D 621.1 766.2 A,B 0.11 A,B
G 2 15.1 B 509.6 I 226.6 D 751.3 824.5 A,B 0.05 A
G 3 14.8 C 460.6 H 212.9 D 688.3 778.1 A,B 0.12 A,B
G 4 11.0 A 505.6 I 212.9 D 729.5 855.1 B 0.05 A
G 5 21.1 C 394.2 G 182.4 C 597.7 757.3 A,B 0.09 A,B
G 6 21.6 C 427.6 G 208.9 D 658.1 703.2 A,B 0.11 A,B
G 7 14.8 B 321.3 F 331.3 E 667.4 765.0 A,B 0.10 A,B
G 8 10.9 A 183.7 D 336.9 E 531.5 731.6 A,B 0.10 A,B
VC * 2.24 2.29 3.13 - 6.14 5.14
* Variation coefficient [%]: median of all relative standard deviations per analysis.
3.2. Stepwise Fractionation According to Solubility and RP-HPLC
The contents of fractions A, B, and C in gluten samples and HWP were determined according to
the modified Osborne fractionation, combining extraction and RP-HPLC analysis [4,7]. The RP-HPLC
chromatograms of the three fractions from gluten (G1) and HWP2 are shown as examples in Figure 1
and those of all other samples are available as Supplementary Material Figures S1–S13. Fraction B
consists of gliadins, whereas fraction C contains glutenins. The contents of fraction B were between
321.3 and 505.6 mg/g and fraction C between 182.4 and 331.3 mg/g. The contents of fraction B in G3, G7,
and G8 were significantly different to each other and to other gluten samples as well as HWP (Table 1).
Residues of albumins and globulins, present in fraction A, were determined (11.0–21.6 mg/g). They are
mostly washed out during the gluten extraction process of wheat gluten but not completely. The
content of fraction A was similar for gluten samples in most cases. The contents of the three fractions
were similar for G8 (A: 10.9 mg/g, B: 183.7 mg/g, C: 336.9 mg/g) compared to the untreated gluten
samples (G1–G6). G7 (A: 14.8 mg/g, B: 321.3 mg/g, C: 331.3 mg/g) had a similar content of fraction
C but significantly different contents of fraction A and B in relation to G1–G6 and G8 and all HWP
(except fraction A of G2).
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weight- (LMW-) glutenin subunits (fraction C: c,f). 
The contents of fraction A from all HWP (45.8–569.4 mg/g) were significantly higher compared 
to gluten G1–G8. This results from the modification process where gluten proteins are degraded to 
smaller proteins, which are consequently more soluble in aqueous solutions. Furthermore, the 
contents of fraction A from HWP1–HWP7 were significantly different to each other. For HWP, the 
contents were between 25.9 and 423.1 mg/g for fraction B and between 15.4 and 162.2 mg/g for 
Figure 1. Reversed-phase high-performance liquid-chromatography: Chromatograms of the three
fractions, soluble in aqueous salt solution (fraction A), soluble in 60% ethanol (fraction B), and soluble
in glutenin extraction solution (fraction C) of gluten G1 (a–c) and hydrolyzed wheat protein HWP2
(d–f). Albumins and globulins (fraction A: a,d), gliadins subdivided into ω5-, ω1,2-, α-, and
γ-gliadins (fraction B: b, ), and glutenins subdivided into high-molecular-weight- (HMW-) and
low-molecular-weight- (LMW-) glutenin subunits (fraction C: c,f).
The contents of fraction A from all HWP (45.8–569.4 mg/g) were significantly higher compared
to gluten G1–G8. This results from the modification process where gluten proteins are degraded to
smaller proteins, which are consequently more soluble in aqueous solutions. Furthermore, the contents
of fraction A from HWP1–HWP7 were significantly different to each other. For HWP, the contents
were between 25.9 and 423.1 mg/g for fraction B and between 15.4 and 162.2 mg/g for fraction C. For
HWP1 and HWP3, the contents of fraction B were lower than 2.3 mg/g. This value was estimated by
injecting decreasing amounts of PWG-gliadin and checking the linearity of the calibration curve. For
HWP1, HWP2, and HWP3, the contents of fraction C were lower than 4.7 mg/g. HWP2 and HWP5 had
a significantly lower content of fraction B than the other HWP and G1–G8.
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3.3. Gel-Permeation High-Performance Liquid Chromatography (GP-HPLC)
To have a closer look at the different HWP and modified gluten samples, fractions I, II, and III
were analyzed by GP-HPLC to determine the Mr distribution of the proteins and peptides using
two chromatographic systems (I and II). After the extraction of fractions I and II according to the
modified Osborne fractionation, fraction III was extracted with a water-acetonitrile mixture (50/50, v/v).
It was impossible to use the glutenin extraction solution, as commonly used in the modified Osborne
fractionation combined with RP-HPLC, because it generated a broad interfering signal in the GP-HPLC
chromatogram at a retention time of 6.9 min in system I. The chromatograms of the three fractions
analyzed by the two GP-HPLC systems are shown in Figure 2 for HWP2 and the quantitative results
are presented in Tables 2 and 3. The GP-HPLC chromatograms of all other HWP samples and of G7
and G8 are available as Supplementary Material Figures S14–S29.
Table 2. Gel-permeation HPLC (system I): Analysis of fractions I, II, and III of treated gluten (G7 and G8)
and hydrolyzed wheat proteins (HWP1–HWP7) according to their relative molecular mass distribution.
Areas within each fraction were set by marker substances. 1: 200–66 kDa; 2: 66–29 kDa; 3: 29–14 kDa; 4:
< 14 kDa. Values are given as means (n = 3) and different capital letters indicate significant differences
between the samples in each column (one-way ANOVA, Tukey’s post hoc test, p < 0.05). “-” integration
not possible, because the area under the curve was not different to baseline.
Sample Fraction I Fraction II Fraction III
1 2 3 4 1 2 3 4 1 2 3 4
[%] [%] [%] [%] [%] [%] [%] [%] [%] [%] [%] [%]
HWP 1 - - - 100.0 B - - - - - - - -
HWP 2 - 1.5 A 6.5 D 92.0 A,B - 17.0 B 32.6 A,B,C 50.4 C - - - -
HWP 3 - - - 100.0 B - - - - - - - -
HWP 4 - 2.3 A,B 5.0 C 92.7 A,B 14.0 C 16.1 A,B 26.2 A,B,C 43.7 B,C 60.2 A,B 14.3 A,B 9.8 A,B 15.7 A,B
HWP 5 11.6 A 10.6 B 11.6 F 66.2 A 39.5 F 14.2 A 9.7 A 36.6 A,B,C 52.0 A,B 14.3 A,B 8.3 A,B 25.4 A,B
HWP 6 7.3 B 9.7 A,B 15.6 G 67.4 A 31.6 E 15.2 A,B 16.4 A,B 36.8 A,B,C 63.5 B 13.4 A,B 7.8 A 15.3 A,B
HWP 7 - 4.0 A,B 8.8 E 87.2 A,B 31.0 D,E 16.9 B 24.6 A,B,C 27.5 A 61.3 A,B 12.2 A 11.7 A,B 14.8 A
G 7 - - 3.5 B 96.5 A,B 11.3 B 15.1 A,B 39.5 B,C 34.1 A,B 30.7 A,B 12.1 A 37.6 A,B 19.6 A,B
G 8 - - 2.0 A 98.0 A,B 5.8 A 14.7 A,B 42.9 C 36.6 A,B,C 11.7 A 15.3 B 45.0 B 28.0 B
CV * [%] 8.8 4.9 4.9 0.7 2.8 1.3 3.6 2.1 3.3 2.3 6.5 5.5
* Variation coefficient: median of all relative standard deviations per analysis.
HWP1 and HWP3 both contained only proteins/peptides with Mr below 14 kDa in fraction I. No
peaks were detectable anymore in fractions B and C of the modified Osborne fractionation (Table 1) and
consequently, fractions II and III in the GP-HPLC system I also showed no AUC. This clearly shows
that HWP1 and HWP3 were extensively hydrolyzed. The Mr distribution of HWP2 showed 92.0% of
proteins/peptides with an Mr below 14 kDa, 6.5% with an Mr of 14–29 kDa, and 1.5% with an Mr of
66–29 kDa in fraction I. In fraction II, the distribution of Mr changed, but 50.4% of the proteins/peptides
were still below 14 kDa. No signals were detected in fraction III of HWP2, as expected from fraction C.
All other HWP4–HWP7 as well as G7 and G8 displayed signals above the estimated threshold in all
three fractions (Table 2). HWP5 and HWP6 showed quite similar Mr distributions in fractions I, II,
and III (Table 2). HWP4 and HWP7 contained no proteins/peptides with Mr 200–66 kDa in fraction
I. Furthermore, they had low percentages for Mr 29–66 kDa (2.3–4.0%) and Mr 14–29 kDa (5.0–8.8%)
but high percentages for Mr < 14 kDa (87.2–92.7%) in fraction I. Both fractions II and III of HWP7 had
similar percentages in Mr as HWP6. Fraction II of HWP4 showed a different Mr distribution compared
to the other samples, whereas fraction III was comparable to HWP6 and HWP7. The treated gluten
samples G7 and G8 were comparable in the percentages of Mr in all fractions.
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Table 3. Gel-permeation HPLC (system II): Analysis of fractions I, II, and III of treated gluten (G7 and G8)
and hydrolyzed wheat proteins (HWP1-HWP7) according to their relative molecular mass distribution.
Areas within each fraction were set by marker substances. 1: ≥ 14 kDa; 2: 14–2 kDa; 3: < 2 kDa. Values
are given as means (n = 3) and different capital letters indicate significant differences between the
samples in each column (one-way ANOVA, Tukey’s post hoc test, p < 0.05). “-” integration not possible,
because the area under the curve was not different to baseline.
Sample Fraction I Fraction II Fraction III
1 2 3 1 2 3 1 2 3
[%] [%] [%] [%] [%] [%] [%] [%] [%]
HWP 1 16.8 B 33.9 G 49.3 F - - - - - -
HWP 2 66.3 E 18.8 F 14.9 B 100.0 - - - - -
HWP 3 3.9 A 39.1 H 57.0 G - - - - - -
HWP 4 75.3 I 13.7 E 11.0 A 100.0 - - 100.0 - -
HWP 5 73.7 G,H,I 11.5 D 14.8 B 100.0 - - - - -
HWP 6 74.2 H,I 4.5 B,C 21.3 C 100.0 - - 100.0 - -
HWP 7 70.5 F 5.6 C 23.9 D 100.0 - - 100.0 - -
G 7 53.3 D 2.5 A 44.2 E 100.0 - - 100.0 - -
G 8 31.6 C - 68.4 H 100.0 - - 100.0 - -
CV * [%] 2.0 2.9 2.6 0.0 - - 0.0 - -
* Variation coefficient: median of all relative standard deviations per analysis.
The GP-HPLC system II was established to have a closer look at proteins/peptides with low
Mr (Table 3). As expected from the Osborne fractionation (Table 1), HWP1 and HWP3 only showed
baseline values in fractions II and III. The Mr distribution in fraction I of HWP1 and HWP3 was
significantly different to all other samples and to each other. HWP1 had significantly higher percentages
of proteins/petides with Mr ≥ 14 kDa but lower percentages of proteins/petides with Mr < 2 kDa
compared to HWP3. In fraction I, the Mr of HWP2 was mostly≥ 14 kDa (66.3%), whereas the percentage
of peptides with an Mr < 2 kDa was similar to that of HWP5. HWP4 and HWP5 as well as HWP6 and
HWP7 showed comparable Mr distributions in fraction I, respectively. Considering fractions II and III,
HWP1 and HWP3 only had baseline values, indicating that the samples were completely soluble in
aqueous salt solution. HWP2 and HWP5 showed no peaks in fraction III, but fraction II contained
100% of proteins/peptides with Mr ≥ 14 kDa.
When comparing the results from RP-HPLC and GP-HPLC analyses, we found 15.4 mg/g of
fraction C in HWP5 after extraction/RP-HPLC analysis (Table 1) but no signal above the baseline
after extraction/GP-HPLC analysis. This discrepancy can be explained with the change of extraction
solvents for both analyses. Apparently, the glutenin extraction solution with DTT used in combination
with RP-HPLC (fraction C) is more efficient at extracting the proteins/peptides from the sample than
the water-acetonitrile mixture used for GP-HPLC (corresponding fraction III). The difference was
small and only apparent for HWP5, because it had such low contents of fraction C/III. HWP4, HWP6,
and HWP7 had 100% of proteins/peptides with Mr ≥ 14 kDa in fractions II and III, respectively, as did
G7 and G8. The Mr distribution of G7 and G8 was significantly different from HWP1–HWP7 in fraction
I. G8 was the only sample with no AUC in the range of Mr 14–2 kDa. G7 and G8 were also significantly
different to each other, which is according to expectations, because they were treated in different ways.
3.4. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
Two different reducing buffer systems, using MES and MOPS, were tested for SDS-PAGE. Overall,
the gels looked similar regarding band patterns, but the bands were sharper with MOPS compared
Biomolecules 2020, 10, 1227 11 of 15
to MES. Consequently, the SDS-PAGE gels with MOPS running buffer are discussed in the following
(Figure 3). The protein marker contained proteins with 15 and 10 kDa, but these bands were not
separated at the end of the gel, so that all bands in this range were designated as Mr ≤ 15 kDa.
Biomolecules 2020, 10, x 12 of 16 
3.4. Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Two different reducing buffer systems, using MES and MOPS, were tested for SDS-PAGE. 
Overall, the gels looked similar regarding band patterns, but the bands were sharper with MOPS 
compared to MES. Consequently, the SDS-PAGE gels with MOPS running buffer are discussed in the 
following (Figure 3). The protein marker contained proteins with 15 and 10 kDa, but these bands 
were not separated at the end of the gel, so that all bands in this range were designated as Mr ≤ 15 
kDa.  
Gluten protein types have different Mr, ranging from HMW-GS with 65–90 kDa, to LMW-GS 
with 30–50 kDa and to gliadins with 28–55 kDa. Among gliadins, the Mr ranges are 49–55 kDa for ω5-
gliadins, 39–44 kDa for ω1,2-gliadins, and 28–39 kDa for α- and γ-gliadins. Veraverbeke et al. and 
Lagrain et al. reported that the Mr of HMW-GS is overestimated to 80–120 kDa in SDS-PAGE due to 
aggregation effects This is visible in all gluten samples (G1–G8), with three characteristic bands of 
HMW-GS in this range. In general, the native gluten samples (G1–G6) showed the typical protein 
bands of the different gluten protein types. A protein band with Mr ≤ 15 kDa was also present in each 
native gluten sample (G1–G6), which results from residues of albumins and globulins (see also 3.2., 
fraction A) [1,6,7,39]. 
The treated gluten samples G7 and G8 showed the same protein bands as the native gluten 
samples G1–G6, indicating that the treatment did not cause extensive changes in the protein 
composition. In contrast, the HWP were completely different. Depending on their degree of 
hydrolysis, they showed more or fewer protein bands. HWP4 and HWP7 showed protein bands in 
the range of 30–50 kDa and approximately 60 and 85 kDa, but they were much more blurred 
compared to G1–G8. HWP5 and HWP6 showed only blurred lanes with no discernible protein bands. 
HWP2, HWP5, and HWP6 showed one band at Mr ≤ 15 kDa, which was also visible in G1–G8, as well 
as HWP4 and HWP7. HWP1 and HWP3 showed no protein bands at all, indicating that they had 
been extensively hydrolyzed. 
 
Figure 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of gluten samples (G1–G8) and 
hydrolyzed wheat proteins (HWP1–HWP7). Protein marker 3.5 µg, samples 15 µg. 
3.5. Contents of Free Ammonium 
The content of free ammonium in a sample is an indicator for hydrolysis under drastic 
conditions, like highly concentrated mineral acids and high temperature, or the use of deamidating 
enzymes, such as transglutaminases [9]. The native gluten samples (G1–G6) had low contents of free 
ammonium (0.05–0.12 mg/g) (Table 1), as did the treated gluten samples (G7–G8: 0.10 mg/g). 
However, the values were higher (0.13–5.00 mg/g) for HWP. This was expected and depends on the 
Figure 3. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of gluten samples (G1–G8) and
hydrolyzed wheat proteins (HWP1–HWP7). Protein marker 3.5 µg, samples 15 µg.
Gluten protein types have different Mr, ranging from HMW-GS with 65–90 kDa, to LMW-GS
with 30–50 kDa a d to gliadins with 28–55 kD . Among gl a ns, the Mr ranges are 49–55 kDa for
ω5-gliadins, 39–44 kDa forω1,2-glia ins, and 28–39 kDa for α- and γ-gliadins. Veraverbeke et l. and
Lagrain et al. reported that the Mr of HMW-GS is overestimated to 80–120 kDa in SDS-PAGE du to
aggregation effects This is visible in all gluten samples (G1–G8), with three characteristic bands of
HMW-GS in this range. In general, the native gluten samples (G1–G6) showed the typical protein
bands of the different gluten protein types. A protein band with Mr ≤ 15 kDa was also present in
each native gluten sample (G1–G6), which results from residues of albumins and globulins (see also
Section 3.2, fraction A) [1,6,7,39].
The treated gluten samples G7 and G8 showed the same protein bands as the native gluten samples
G1–G6, indicating that the treatment did not cause extensive changes in the protein composition.
In contrast, the HWP were completely different. Depending on their degree of hydrolysis, they showed
more or fewer protein bands. HWP4 and HWP7 showed protein bands in the range of 30–50 kDa
and approximately 60 and 85 kDa, but they were much more blurred compared to G1–G8. HWP5
and HWP6 showed only blurred lanes with no discernible protein bands. HWP2, HWP5, and HWP6
showed one band at Mr ≤ 15 kDa, which was also visible in G1–G8, as well as HWP4 and HWP7. HWP1
and HWP3 showed no protein bands at all, indicating that they had been extensively hydrolyzed.
3.5. Contents of Free Ammonium
The content of free ammonium in a sample is an indicator for hydrolysis under drastic conditions,
like highly concentrated mineral acids and high temperature, or the use of deamidating enzymes,
such as transglutaminases [9]. The native gluten samples (G1–G6) had low contents of free ammonium
(0.05–0.12 mg/g) (Table 1), as did the treated gluten samples (G7–G8: 0.10 mg/g). However, the values
were higher (0.13–5.00 mg/g) for HWP. This was expected and depends on the production process.
HWP1 and HWP3 had the highest contents of free ammonium (4.12 and 5.00 mg/g, respectively). G2
and HWP3 had significantly different contents of free ammonium.
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As shown with RP-HPLC, GP-HPLC, and SDS-PAGE, HWP1 and HWP3 were both extensively
hydrolyzed wheat protein samples. These two samples may have been processed via hydrolysis with
mineral acid under heating, which is a very common procedure in the food industry. As shown above,
HWP2 has also been extensively hydrolyzed. In contrast to HWP1 and HWP3, the ammonium content
of HWP2 was low (0.59 mg/g) and this could be an indicator that HWP2 might have been hydrolyzed
enzymatically, with a long duration [9].
4. Discussion
Gluten and HWP showed similarities in the crude protein contents (about 765 mg/g) and these
contents were expected for gluten [1]. This shows that the treatment of the HWP did not change the
crude protein content, except for HWP 5. The content of free ammonium was used as an indicator
for deamidation. Consequently, higher values were expected for the HWP compared to gluten and
the results supported the expectation, because HWP had average contents of 1.56 mg/g and gluten
of 0.09 mg/g. No exact contents have been reported in the literature so far, but it is known that
deamidation may take place during hydrolysis and is also carried out intentionally to achieve the
desired functional properties, such as increased solubility [8,9].
The most remarkable differences between gluten and HWP were the contents of fraction A of the
modified Osborne fractionation. HWP (on average: 341.6 mg/kg) showed significantly higher contents
than gluten (on average: 16.0 mg/kg), according to expectations. Crude gluten is treated in chemical
and biochemical ways to improve solubility. Consequently, a higher percentage of proteins or peptides
is soluble in salt solution and does not require organic solvents or reducing agents anymore to become
soluble, like intact gliadins and glutenins do. The extent of the increase in solubility and thus contents
of fraction A depend on the type and degree of processing. Consequently, with increased contents in
fraction A, HWP had decreased contents in fraction B and C. Among others, Kanerva et al. (2011) and
Wu et al. (1976) described a noticeably increased solubility of HWP compared to gluten [9,28].
In agreement with the RP- and GP-HPLC results, differences were also visible between gluten
and HWP using SDS-PAGE. While gluten showed typical protein bands, the HWP showed less or
even no protein bands, because of protein degradation. Generally, the protein bands were weaker in
HWP than in gluten, which was expected. Wieser et al. (2018) showed a change in protein bands
in SDS-PAGE relative to the duration of hydrolysis [32]. However, the degree of hydrolysis and the
presence of protein bands in SDS-PAGE is not only dependent on the duration but also on the type of
hydrolysis. Chemical hydrolysis is usually harsher than enzymatic digestion [8,12,32,40].
Interestingly, in SDS-PAGE, a protein band was found at Mr ≤ 15 kDa in G1–G8 and in most
HWP samples, except HWP1 and HWP3. In the GP-HPLC system I, this is also clearly visible in
area 4 of fraction I (Mr < 14 kDa), which had the highest percentage in the fraction of these samples.
Additionally, in the GP-HPLC system II, the highest percentage was present in area 1 of fraction I
(Mr ≥14 kDa) for HWP2, 4–7 and G7. This indicates the presence of proteins with Mr around about
14 kDa or lower. This may result from, e.g., α-amylase/trypsin-inhibitors that have a Mr of about
12–16 kDa, but further analyses are required to unambiguously identify these proteins [41].
HWP1 and HWP3 did not show any protein bands in SDS-PAGE, which indicated the status of
total hydrolysis. This is also visible in their GP-HPLC measurements, showing Mr lower than 14 kDa in
both systems. Such an extensive hydrolysis can be carried out with the use of 0.5–1 mol/L hydrochloric
acid and boiling [9,28].
Furthermore, the HWP were different from each other in many cases. The contents of fractions A
and B were significantly different in every HWP. Additionally, differences in Mr using GP-HPLC were
visible. It was predictable that HWP were different from each other, because many different approaches
for gluten hydrolysis are in use like treatment with chemicals [13] and enzymes or high-pressure
processing and UV irradiation [8].
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The differences between native gluten and HWP are likely to result in difficulties regarding gluten
analysis, important for people with wheat-related disorders, who need to avoid gluten. The identified
differences between HWP support the allegation that their determination is challenging [9,33,35].
In general, it should be noted that the differences between gluten and HWP need to be considered
when developing analytical methods, e.g., because sample preparation is affected due to different
solubility. Another point is that reference materials used for calibration may need to be adapted or
that different assay formats may be necessary, i.e., a competitive ELISA as opposed to a sandwich
format [31,35]. Regarding diagnostic approaches, the immunoreactivity might differ greatly, as the
differences found at the molecular level suggest. The same applies to different HWP, because their
properties are highly variable. The in-depth characterization of the samples allowed us to select
particularly interesting HWP samples showing a low or a high degree of hydrolysis for further
work to characterize the sensitization profiles in wheat allergic patients. Testing the levels of gluten
immunogenic peptides arising after the ingestion of gluten or HWP in patients’ urine or stool samples
would be very interesting to assess potential differences in bioaccessibility, bioavailability, and uptake
vs. excretion ratios [42].
How the identified molecular differences influence the mechanisms of celiac disease and wheat
allergy is hard to say. On the one hand, hydrolysis uncovers immunoactive epitopes in the proteins
and potentially generates new ones by deamidation. In addition, the increased solubility of HWP may
have an influence on the bioavailability and digestibility in the body. On the other hand, hydrolysis
can also destroy immunoactive epitopes, because of extensive protein degradation [19–22].
5. Conclusions
Commercially available HWP and gluten samples were characterized according to their crude
protein content, solubility, and Mr of the proteins and peptides as well as the content of free ammonium
as indicator for deamidation. Differences in the protein composition, solubility, and Mr distribution
between HWP and native gluten were expected and found, especially for the solubility of HWP and
gluten in aqueous salt solution. Additionally, all analyzed HWP were significantly different from
each other. This shows that the molecular characteristics of HWP generally are highly variable and
that these are likely to cause differences in the immunoreactivity of the products. These findings
highlight that the exact characterization of HWP products is very important to establish relationships
between protein structure and immunoreactivity for patients suffering from wheat-related disorders.
It is necessary to pay attention to the molecular differences between gluten and HWP, especially for the
development of analytical or diagnostic methods.
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